Patents by Inventor Masamichi Toba
Masamichi Toba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230027710Abstract: In an information providing method, purchase data indicating a purchase history of a control customer is acquired, and a merchandise category to which at least one merchandise belongs is determined from the purchase data. In this method, an extent of a potential health symptom of a target customer is further predicted using a health predictive model having the merchandise category to which at least one merchandise included in the purchase history belongs and an extent of the health symptom correlated therein, and the merchandise category. In the method, health information indicating the extent of the predicted health symptom is provided to the target customer.Type: ApplicationFiled: May 27, 2022Publication date: January 26, 2023Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Yasushi NAKAGAWA, Naoyuki DEGUCHI, Keisuke HAMAMOTO, Masamichi TOBA, Soh IWASHITA, Mina TSUBOUCHI, Kyungtak KWAK, Miho YOSHIE
-
Patent number: 10369177Abstract: [Object] An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. [Method for Achieving the Object] A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).Type: GrantFiled: April 17, 2017Date of Patent: August 6, 2019Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Mina Tsubouchi, Takao Saito, Masamichi Toba, Noriyuki Kouda, Shoji Shinkai
-
Publication number: 20170216379Abstract: [Object] An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. [Method for Achieving the Object] A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).Type: ApplicationFiled: April 17, 2017Publication date: August 3, 2017Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Mina TSUBOUCHI, Takao SAITO, Masamichi TOBA, Noriyuki KOUDA, Shoji SHINKAI
-
Patent number: 9623054Abstract: An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. [Method for Achieving the Object] A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).Type: GrantFiled: March 28, 2012Date of Patent: April 18, 2017Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Mina Tsubouchi, Takao Saito, Masamichi Toba, Noriyuki Kouda, Shoji Shinkai
-
Publication number: 20140017217Abstract: An object of the present invention is to provide a QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent. Method for Achieving the Object A QOL improving or sustaining agent, a physical health improving or sustaining agent, a vitality improving or sustaining agent, a fatigue recovery or alleviating agent, or an anti-fatigue agent containing Lactobacillus ONRICb0240 (FERM BP-10065).Type: ApplicationFiled: March 28, 2012Publication date: January 16, 2014Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Mina Tsubouchi, Takao Saito, Masamichi Toba, Noriyuki Kouda, Shoji Shinkai
-
Patent number: 8182849Abstract: The present invention provides a tea-based fermentation beverage comprising a tea-based fermentation liquid with at least one species of lactic acid bacteria selected from the group consisting of Lactobacillus ONRIC b0239 (FERM BP-10064) and Lactobacillus ONRIC b0240 (FERM BP-10065), and a tea beverage comprising at least one species of lactic acid bacteria selected from the group consisting of Lactobacillus ONRIC b0239 (FERM BP-10064) and Lactobacillus ONRIC b0240 (FERM BP-10065).Type: GrantFiled: February 22, 2006Date of Patent: May 22, 2012Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Rieko Endo, Po Sheng Wu, Satoko Yamahira, Masamichi Toba, Hiroshi Okamatsu
-
Patent number: 7842495Abstract: The invention provides lactic acid bacteria selected from the group consisting of lactobacillus ONRIC b0239 (FERM BP-10064) and lactobacillus ONRIC b0240 (FERM BP-10065), and compositions containing the bacteria, the compositions being capable of stimulating mucosal immunity, and more specifically, the compositions in the form of foods or beverages or pharmaceutical products. The lactic acid bacteria and compositions containing the bacteria are capable of providing excellent mucosal immunostimulation effects and are useful for reinforcing the host defense system.Type: GrantFiled: August 18, 2004Date of Patent: November 30, 2010Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoko Yamahira, Masamichi Toba, Hiroshi Okamatsu
-
Publication number: 20100159072Abstract: The present invention provides a tea-based fermentation beverage comprising a tea-based fermentation liquid with at least one species of lactic acid bacteria selected from the group consisting of Lactobacillus ONRIC b0239 (FERM BP-10064) and Lactobacillus ONRIC b0240 (FERM BP-10065), and a tea beverage comprising at least one species of lactic acid bacteria selected from the group consisting of Lactobacillus ONRIC b0239 (FERM BP-10064) and Lactobacillus ONRIC b0240 (FERM BP-10065).Type: ApplicationFiled: February 22, 2006Publication date: June 24, 2010Applicant: Otsuka Pharmaceutical Co., Ltd.Inventors: Rieko Endo, Po Sheng Wu, Satoko Yamahira, Masamichi Toba, Hiroshi Okamatsu
-
Publication number: 20060182727Abstract: The invention provides lactic acid bacteria selected from the group consisting of lactobacillus ONRIC b0239 (FERM BP-10064) and lactobacillus ONRIC b0240 (FERM BP-10065), and compositions containing the bacteria, the compositions being capable of stimulating mucosal immunity, and more specifically, the compositions in the form of foods or beverages or pharmaceutical products. The lactic acid bacteria and compositions containing the bacteria are capable of providing excellent mucosal immunostimulation effects and are useful for reinforcing the host defense system.Type: ApplicationFiled: August 18, 2004Publication date: August 17, 2006Inventors: Satoko Yamahira, Masamichi Toba, Hiroshi Okamatsu
-
Patent number: 6884415Abstract: The antioxidation food product of the present invention is produced by fermenting a food product containing bacteria having catalase activity, such as Lactobacillus plantarum, in the presence of a manganese-containing natural material. The antioxidation food product has antioxidation activity in viva, including the digestive tract, by simultaneously expressing a superoxide dismutase-like activity and a catalase activity, and is effective for preventing disease caused by active oxygen.Type: GrantFiled: December 21, 2001Date of Patent: April 26, 2005Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Masamichi Toba, Shigeto Uchiyama, Reiko Ohta, Seiichi Shimizu, Shuichi Sakamoto
-
Patent number: 6468556Abstract: A method of inhibiting liver fat accumulation which comprises administering a conjugated linoleic acid homolog to a mammal or making the mammal ingest it; and a liver fat accumulation inhibitory composition characterized by containing an effective amount of a conjugated linoleic acid homolog together with a support for medicinal preparations or foods. The administration or ingestion of CLA inhibits the total lipid content and the triglyceride content in the liver from increasing, and hence can effectively prevent diseases attributable to fatty liver, such as chronic hepatitis and hepatic cirrhosis.Type: GrantFiled: March 3, 2000Date of Patent: October 22, 2002Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Tsuneyuki Noda, Masamichi Toba, Takuma Imada, Kyosuke Masaki, Seiichi Shimizu
-
Publication number: 20020064518Abstract: The antioxidation food product of the present invention is a fermented product produced by adding a manganese-containing natural material such as tea and fermenting with bacteria having a catalase activity (e.g. Lactobacillus plantarum). The antioxidation food product has an antioxidation action in the living body including the interior of a digestive tract by expressing a superoxide dismutase-like activity and a catalase activity, simultaneously, and is effective for preventing diseases caused by active oxygen.Type: ApplicationFiled: December 21, 2001Publication date: May 30, 2002Inventors: Masamichi Toba, Shigeto Uchiyama, Reiko Ohta, Seiichi Shimizu, Shuichi Sakamoto
-
Patent number: 6228358Abstract: The antioxidation food product of the present invention is produced by fermenting a food product containing bacteria having catalase activity, such as Lactobacillus plantarum, in the presence of a manganese-containing natural material. The antioxidation food product has antioxidation activity in vivo, including the digestive tract, by simultaneously expressing a superoxide dismutase-like activity and a catalase activity, and is effective for preventing diseases caused by active oxygen.Type: GrantFiled: January 10, 1995Date of Patent: May 8, 2001Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Masamichi Toba, Shigeto Uchiyama, Reiko Ohta, Seiichi Shimizu, Shuichi Sakamoto